These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 20302575)

  • 1. The effect of visible light and near-infrared radiation on constitutive pigment of patients with vitiligo.
    Seo I; Baqer A; Kollias N
    Br J Dermatol; 2010 Jul; 163(1):211-3. PubMed ID: 20302575
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of efficacy of the Q-switched ruby laser in the treatment of vitiligo.
    Renfro L; Geronemus RG
    Arch Dermatol; 1992 Feb; 128(2):277-8. PubMed ID: 1739317
    [No Abstract]   [Full Text] [Related]  

  • 3. Ultraviolet A in vitiligo.
    El-Mofty M; Mostafa W; Youssef R; El-Fangary M; Elramly AZ; Mahgoub D; Fawzy M
    Photodermatol Photoimmunol Photomed; 2006 Aug; 22(4):214-6. PubMed ID: 16869873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot study to determine the safety and efficacy of monochromatic excimer light in the treatment of vitiligo.
    Chimento SM; Newland M; Ricotti C; Nistico S; Romanelli P
    J Drugs Dermatol; 2008 Mar; 7(3):258-63. PubMed ID: 18380207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical tacalcitol and 308-nm monochromatic excimer light: a synergistic combination for the treatment of vitiligo.
    Lu-yan T; Wen-wen F; Lei-hong X; Yi J; Zhi-zhong Z
    Photodermatol Photoimmunol Photomed; 2006 Dec; 22(6):310-4. PubMed ID: 17100739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UVB 311 nm tolerance of vitiligo skin increases with skin photo type.
    Caron-Schreinemachers AL; Kingswijk MM; Bos JD; Westerhof W
    Acta Derm Venereol; 2005; 85(1):24-6. PubMed ID: 15848986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Phototherapy with UV-B in vitiligo].
    Köster W; Wiskemann A
    Z Hautkr; 1990 Nov; 65(11):1022-4, 1029. PubMed ID: 2080652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Narrow-band UVB for the treatment of vitiligo: an emerging effective and well-tolerated therapy.
    Kanwar AJ; Dogra S; Parsad D; Kumar B
    Int J Dermatol; 2005 Jan; 44(1):57-60. PubMed ID: 15663664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical tacrolimus may enhance repigmentation with targeted narrowband ultraviolet B to treat vitiligo: a randomized, controlled study.
    Klahan S; Asawanonda P
    Clin Exp Dermatol; 2009 Dec; 34(8):e1029-30. PubMed ID: 20055831
    [No Abstract]   [Full Text] [Related]  

  • 10. Critical evaluation of the variants influencing the clinical response of vitiligo: study of 60 cases treated with ultraviolet B narrow-band phototherapy.
    Brazzelli V; Antoninetti M; Palazzini S; Barbagallo T; De Silvestri A; Borroni G
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1369-74. PubMed ID: 17958843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study.
    Middelkamp-Hup MA; Bos JD; Rius-Diaz F; Gonzalez S; Westerhof W
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):942-50. PubMed ID: 17659004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-energy helium-neon laser therapy induces repigmentation and improves the abnormalities of cutaneous microcirculation in segmental-type vitiligo lesions.
    Wu CS; Hu SC; Lan CC; Chen GS; Chuo WH; Yu HS
    Kaohsiung J Med Sci; 2008 Apr; 24(4):180-9. PubMed ID: 18424354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal weekly frequency of 308-nm excimer laser treatment in vitiligo patients.
    Hofer A; Hassan AS; Legat FJ; Kerl H; Wolf P
    Br J Dermatol; 2005 May; 152(5):981-5. PubMed ID: 15888156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repigmentation of vitiligo with punch grafting and narrow-band UV-B (311 nm)--a prospective study.
    Lahiri K; Malakar S; Sarma N; Banerjee U
    Int J Dermatol; 2006 Jun; 45(6):649-55. PubMed ID: 16796620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacalcitol and narrow-band phototherapy in patients with vitiligo.
    Leone G; Pacifico A; Iacovelli P; Paro Vidolin A; Picardo M
    Clin Exp Dermatol; 2006 Mar; 31(2):200-5. PubMed ID: 16487090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of visible light-induced melanogenesis in human skin.
    Porges SB; Kaidbey KH; Grove GL
    Photodermatol; 1988 Oct; 5(5):197-200. PubMed ID: 3222167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitiligo Potential Repigmentation Index: a simple clinical score that might predict the ability of vitiligo lesions to repigment under therapy.
    Benzekri L; Ezzedine K; Gauthier Y
    Br J Dermatol; 2013 May; 168(5):1143-6. PubMed ID: 23464539
    [No Abstract]   [Full Text] [Related]  

  • 18. Narrowband UVB therapy for vitiligo: does the repigmentation last?
    Sitek JC; Loeb M; Ronnevig JR
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):891-6. PubMed ID: 17658996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical calcipotriene and narrowband ultraviolet B in the treatment of vitiligo.
    Kullavanijaya P; Lim HW
    Photodermatol Photoimmunol Photomed; 2004 Oct; 20(5):248-51. PubMed ID: 15379875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the effects of NB-UVB in both segmental and non-segmental vitiligo affecting different body sites.
    Anbar TS; Westerhof W; Abdel-Rahman AT; El-Khayyat MA
    Photodermatol Photoimmunol Photomed; 2006 Jun; 22(3):157-63. PubMed ID: 16719871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.